Aberdeen Israel Fund Inc  

(Public, NYSEMKT:ISL)   Watch this stock  
Find more results for Alan Israel�
17.14
-0.16 (-0.91%)
Dec 19 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 17.04 - 17.25
52 week 15.18 - 18.60
Open 17.14
Vol / Avg. 0.00/6,488.00
Mkt cap 70.43M
P/E     -
Div/yield 0.26/1.37
EPS     -
Shares 4.23M
Beta 0.91
Inst. own 24%

Key stats and ratios

2010
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets - -
Return on average equity - -
CDP Score - -

Address

32nd Floor, 1735 Market Street
PHILADELPHIA, PA 19103
United States - Map
+1-866-8395205 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Aberdeen Israel Fund, Inc. (the Fund) is a closed-end fund. The Fund seeks long-term capital appreciation by investing in equity securities of Israeli companies. The Fund has adopted a policy to invest under normal circumstances, at least 80% of the value of its assets in investments, which are tied economically to Israel. Aberdeen Asset Management Investment Services Limited is the Fund�s Investment Adviser.

Officers and directors

Enrique R. Arzac Ph.D. Independent Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Christian A. J. Pittard President
Age: 41
Bio & Compensation  - Reuters
Andrea L. Melia Chief Financial Officer, Treasurer
Age: 45
Bio & Compensation  - Reuters
Jeffrey Cotton Vice President, Chief Compliance Officer
Age: 37
Bio & Compensation  - Reuters
Alan R. Goodson Vice President, Secretary
Age: 40
Bio & Compensation  - Reuters
Megan Kennedy Vice President, Secretary
Age: 40
Bio & Compensation  - Reuters
Joanne C. Irvine Vice President
Age: 46
Bio & Compensation  - Reuters
Devan Kaloo Vice President
Age: 42
Bio & Compensation  - Reuters
Jennifer A. Nichols Vice President
Age: 36
Bio & Compensation  - Reuters
Nick Robinson Vice President
Age: 36
Bio & Compensation  - Reuters